|
|
#1
07-15-2016, 06:09 AM
|
|||
|
|||
UK charity pockets $150 mln from Merck cancer immu**therapy drug
LONDON :British medical charity MRC Tech**logy has pocketed 0 million by selling part of its
royalty interest in Merck & Co´s successful cancer drug Keytruda, allowing it to plough fresh funds into new research. The charity said on Friday that a private equity fund managed by DRI Capital had acquired a portion of its royalty entitlement on the worldwide sales of the medicine. Keytruda is one of a promising class of new treatments that stimulate the body´s immune system to fight cancer. It is an antibody-based medicine and was "humanised" by scientists at MRC Tech**logy. أكثر... ??????? ??????: UK charity pockets $150 mln from Merck cancer immu**therapy drug || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري